• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aquestive Therapeutics Inc (NQ: AQST )

    5.520 +0.030 (+0.55%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Aquestive Therapeutics Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Dow Surges 350 Points; Fed Holds Rates Steady
    U.S. stocks traded higher toward the end of trading, after the Federal Reserve left rates unchanged. The Dow traded up 0.91% to 39,467.76 while the NASDAQ rose 1.08% to 16,341.42. The S&P 500 also... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... 
    Via Benzinga
    Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher
    U.S. stocks traded mostly flat midway through trading, ahead of interest-rate decision from the Federal Reserve. The Dow traded up 0.03% to 39,123.89 while the NASDAQ fell 0.01% to 16,165.15. The S&P... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Fossil Fuels Interest Rates US Equities
    A Preview Of Aquestive Therapeutics's Earnings
    Via Benzinga
    Where Aquestive Therapeutics Stands With Analysts
    Via Benzinga
    Earnings Scheduled For November 6, 2023
    Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
    Via Benzinga
    A Stock Split Catalyst Looms for Chipotle (CMG) Stock on June 6
    Chipotle stock is rising on Wednesday as investors in CMG shares react to the company seeking approval for a 50-for-one split. 
    Via InvestorPlace
    INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
    Intel stock is rising on Wednesday as investors in INTC shares react to the semiconductor company securing $8.5 billion in funding. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is Aquestive Therapeutics (AQST) Stock Down 14% Today?
    Aquestive Therapeutics stock is falling on Wednesday after the company price a public offering for AQST shares this morning. 
    Via InvestorPlace
    Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket
    Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. 
    Via Benzinga
    Preview: Aquestive Therapeutics's Earnings
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning! 
    Via InvestorPlace
    Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    U.S. stock futures were slightly lower this morning, with the Dow futures falling by around 0.1% on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
    Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter earnings. 
    Via Benzinga
    Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates. 
    Via Benzinga
    Aquestive Therapeutics Announces Pivotal Study for Anaphylm™ (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance. 
    Via Benzinga
    AQST Stock Earnings: Aquestive Therapeutics Misses EPS, Beats Revenue for Q4 2023
    AQST stock results show that Aquestive Therapeutics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Earnings Scheduled For March 5, 2024
    Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion. 
    Via Benzinga
    Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data at the 2024 AAAAI Annual Meeting
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics Doses First Patient in Phase 3 Pivotal Clinical Study Evaluating Pharmacokinetics and Pharmacodynamics of Anaphylm™ (epinephrine) Sublingual Film
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm™ at American College of Allergy Asthma and Immunology (ACAAI) Annual Meeting
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.